BlaaskankerZorg In Beeld

Insight into bladder cancer care

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON26633

Enrollment

6500

Registered

2019-10-22

Start date

2017-11-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder cancer

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: All newly diagnosed Dutch patients with High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIB; Cis and T1) and Muscle invasive Bladder Cancer (MIBC; =T2) between November 1st 2017 and end 2019 in the Netherlands.

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
Oncological outcomes (disease recurrence, progression, mortality, disease-free survival and overall survival) and Health-related quality of life	—

Secondary

Measure	Time frame
Complications, toxicity, complete pathological response, downstaging	—

Contacts

Public ContactKatja Aben

Netherlands Comprehensive Cancer Organisation

k.aben@iknl.nl+31646146854

Outcome results